Hypersensitivity to CGRP as a predictive biomarker of migraine prevention with erenumab

Hypersensitivity to CGRP as a Predictive Biomarker for Migraine Prevention with Erenumab

ABSTRACT

Background: This study aimed to assess the predictive value of CGRP-induced migraine attacks for the effectiveness of erenumab treatment in individuals with migraine.

Methods: 139 participants with migraine underwent a 20-minute infusion with CGRP, followed by a 24-week treatment period with erenumab. The primary endpoints were the predictive value of CGRP-induced migraine attacks on the effectiveness of erenumab, defined as a ≥50% reduction in monthly migraine days or a ≥50% reduction in either monthly migraine or monthly headache days of moderate to severe intensity.

Results: Among participants with CGRP-induced migraine attacks, 60 out of 99 (61%) achieved a ≥50% reduction in monthly migraine days during weeks 13-24 with erenumab. Conversely, 13 out of 25 (52%) where CGRP infusion did not induce a migraine achieved the same endpoint (p = 0.498). There were no significant differences between the ≥50% reduction in either monthly migraine or monthly headache days of moderate to severe intensity between CGRP-sensitive and non-sensitive participants (p = 0.625).

Conclusions: The findings suggest that the CGRP-provocation model cannot be used to predict erenumab’s effectiveness. It remains uncertain whether this finding extends to other monoclonal antibodies targeting the CGRP ligand or to gepants. Trial Registration: The study was registered at ClinicalTrials.gov (NCT04592952).

PMID: 38859744 | DOI: 10.1177/03331024241258734

Clinical Trials and Practical Solutions

Clinical trials play a crucial role in developing safe and effective treatments. It is essential to translate their benefits into everyday medical practice. Our AI-driven platform, DocSym, consolidates ICD-11 standards, clinical protocols, and research into a single, easily accessible knowledge base for clinicians.

Value in Healthcare Operations

In today’s healthcare environment, streamlining operations is essential. Our mobile apps support scheduling, monitoring treatments, and telemedicine, making it easier to manage patient care and expand services digitally.

By utilizing AI, clinics can enhance their workflows, improve patient outcomes, and reduce paper routine. Learn more about how we can help at aidevmd.com.

AI Products for Business or Try Custom Development

AI Sales Bot

Welcome AI Sales Bot, your 24/7 teammate! Engaging customers in natural language across all channels and learning from your materials, it’s a step towards efficient, enriched customer interactions and sales

AI Document Assistant

Unlock insights and drive decisions with our AI Insights Suite. Indexing your documents and data, it provides smart, AI-driven decision support, enhancing your productivity and decision-making.

AI Customer Support

Upgrade your support with our AI Assistant, reducing response times and personalizing interactions by analyzing documents and past engagements. Boost your team and customer satisfaction

AI Scrum Bot

Enhance agile management with our AI Scrum Bot, it helps to organize retrospectives. It answers queries and boosts collaboration and efficiency in your scrum processes.